A Patient Approach to Aggressive Growth
Although performance can be lumpy, Silver-rated ClearBridge Aggressive Growth has delivered great returns by holding on to fast-growing, quality businesses for the long haul.
Although performance can be lumpy, Silver-rated ClearBridge Aggressive Growth has delivered great returns by holding on to fast-growing, quality businesses for the long haul.
David Kathman: ClearBridge Aggressive Growth (SHRAX) is a $15 billion fund and has an Morningstar Analyst Rating of Silver. It's had a variety of names over the years. For a long time, it was known as Smith Barney Aggressive Growth and then Legg Mason Partners Aggressive Growth. But for all of that time, it's been managed by Richie Freeman, who has been around since 1983; although since 2009, he's had a comanager, Evan Bauman.
As the name implies, they look for companies that are growing quite a bit faster than the S&P 500, preferably high-quality companies without a lot of debt--good businesses. What makes this fund stand out from its peers is that it has really low turnover. They have a really long time horizon and hang on to stocks for a long time. That's led to really great returns over time. Although in the short term, it can be kind of lumpy if the things that they own are out of favor for a while.
That was true for a while back in 2006-07; but then eventually they turned around, and for the past five years, this fund has been one of the best performers in the large-growth category, because of its health-care and, especially, biotech names that have performed spectacularly well. So, it sometimes might take a little bit of patience, but over time it has really rewarded shareholders handsomely.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.